Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Table. 1.

Baseline Characteristics of the Post Hoc Population

Characteristics Probiotic (n = 28) Prebiotic (n = 25) Placebo (n = 25) Total (N = 78) P-value
Age (yr) 37.8 ± 7.9 36.6 ± 8.4 36.0 ± 8.5 36.0 ± 9.0 0.460
Sex 0.490
Woman 20.0 (71.4) 20.0 (80.0) 15.0 (60.0) 55.0 (70.5)
Man 8.0 (28.6) 5.0 (20.0) 10.0 (40.0) 23.0 (29.5)
Weight (kg) 72.2 ± 11.8 73.0 ± 15.8 73.4 ± 13.0 72.8 ± 13.4 0.950
BMI (kg/m2) 26.6 ± 4.2 27.2 ± 5.1 26.8 ± 4.5 26.9 ± 4.5 0.850
Duration of depression (yr)a 1.3 ± 1.8 1.5 ± 1.7 1.4 ± 1.8 1.8 ± 1.8 0.661
Duration of antidepressant therapy (yr)a 1.3 ± 4.5 2.1 ± 3.9 1.5 ± 4.1 1.6 ± 4.2 0.960
Antidepressant medication 0.211
Citalopram 5.0 ± 17.8 1.0 ± 4.0 8.0 ± 30.0 14.0 ± 17.0
Fluoxetine 9.0 ± 32.0 4.0 ± 16.0 2.0 ± 8.0 15.0 ± 19.2
Sertraline 8.0 ± 28.6 14.0 ± 52.0 8.0 ± 30.0 30.0 ± 38.5
Amitriptyline 4.0 ± 14.0 5.0 ± 20.0 6.0 ± 23.0 15.0 ± 19.2
BDI scoresb 17.6 (14.2-21.5) 19.7 (15.9-24.0) 18.2 (14.3-22.5) 18.5 (3.9-22.8) 0.730

BMI, body mass index; BDI, Beck’s Depression Inventory.

Non-normal data were logarithmica or square rootb transformed and retransformation was performed to display as mean (95% CI).

The quantitative variables are expressed as mean ± SD, number (%), or mean (95% CI).

J Neurogastroenterol Motil 2020;26:486~495 https://doi.org/10.5056/jnm20079
© J Neurogastroenterol Motil